Clinical Impact of "Moderate" Aortic Stenosis and the Potential Benefit of Therapy
Cardiovascular Grand Rounds presented by the Minneapolis Heart Institute Foundation® This presentations features Drs. Paul Sorajja, Nadira Hamid, João Cavalcante and Bilal Murad of the Allina Health Minneapolis Heart Institute

▶︎
Hypertrophic Cardiomyopathy: Myosin Inhibitors in Context | Rob Fraser, MD

▶︎
Transcatheter Aortic Valve Replacement (TAVR)

▶︎
Cardiac Amyloidosis: From Heart Failure to Heart Success | Siu-Hin Wan, MD, FACC, FAHA, FHFSA

▶︎
Revisiting the Role of Cardiac MRI in Hypertrophic Cardiomyopathy | Clerio Azevedo, MD, PhD

▶︎
Aortic Stenosis (Colin M. Barker, MD) Sunday, August 21, 2016

▶︎
Aortic Stenosis Explained Clearly - Diagnosis and Treatment

▶︎
Heart Failure 2026 - Reviewing CCS 2025 Heart Failure Guidelines

▶︎
The Arrhythmogenic Mitral Valve Prolapse | Maurice Sarano, MD

▶︎
Update on the 2022 ACC/AHA Guidelines for Aortic Disease | Kevin Harris, MD & Erik Beckmann, MD

▶︎
Low Flow, Low Gradient AS

▶︎
Current Management of Aortic Stenosis: A Guideline-Based Approach

▶︎
Update on Atrial Fibrillation Management: Rhythm Control Strategies | Joseph Decker, MD

▶︎
ASE 2021 Aortic Stenosis

▶︎
Aortic Stenosis and the TAVI Procedure: Insights from a Cardiologist

▶︎
Cardiogenic Shock: Effect of different drugs and mechanical support devices. Dr Daniel Burkhoff

▶︎
ECS Cardiovascular Protection Aligning Clinical Expertise webinar 19 May

▶︎
Myocarditis: 2026 Update on Management | Leslie Cooper, MD

▶︎
Joint Echo Conference: Aortic Insufficiency

▶︎
Echocardiographic Assessment of Aortic Stenosis

▶︎
